Valentina Tabanelli

12PUBLICATIONS
79CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 24, 2026
Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.

|Feb 10, 2025
Immune Signatures Identify Patient Subsets Deriving Long-Term Benefit From First-Line Rituximab in Follicular Lymphoma.

Ginevra Lolli, Alessandro Davini, Valentina Tabanelli

|Dec 27, 2024
Venetoclax Plus Intensified Chemoimmunotherapy as a Bridge to Allogeneic Stem Cell Transplantation in Richter Syndrome: Report of Two Cases.

Enrico Derenzini, Alessandro Cignetti, Valentina Tabanelli

|Jun 05, 2023
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma.

Annalisa Arcari, Lugi Rigacci, Alessandra Tucci

|Feb 22, 2023
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL.

Saveria Mazzara, Laura Travaini, Francesca Botta

|Feb 03, 2023
Biological features and outcome of diffuse large B-cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective 'Elderly Project' by the Fondazione Italiana Linfomi.

Annalisa Arcari, Valentina Tabanelli, Francesco Merli

Pageof 2

Frequent Collaborators

5 joint publications

Stefano Pileri

3 joint publications

Enrico Derenzini

3 joint publications

Giovanna Motta

3 joint publications

Anna Vanazzi